The Cabinet of Ministers has approved two procurement contracts for medicines used in the treatment of kidney patients and life-threatening infections, valued at Rs. 990 million and USD 702,000, respectively.
According to the Cabinet decisions, approval has been granted to procure 1.1 million bags containing medication used in dialysis treatment for patients suffering from acute or chronic kidney failure.
The medication is used to remove waste products and excess fluids from the bodies of patients undergoing dialysis.
Two bids were received under the International Competitive Procurement procedure.
Following the evaluation of bids and the recommendation of the High-Level Procurement Committee, the Cabinet approved the proposal submitted by the Minister of Health and Mass Media to award the Rs. 990 million contract to Infuxion Lanka (Private) Limited, Sri Lanka.
The medication will be manufactured by Peritone Health SDN BHD, Malaysia.
Meanwhile, the Cabinet has also approved the procurement of 54,000 vials of Liposomal Amphotericin B, 50 mg each, used to treat life-threatening infections, including cryptococcal meningitis and visceral leishmaniasis.
Three bids were received for the procurement under the International Competitive Procurement procedure.
Based on the recommendation of the High-Level Standing Procurement Committee, the contract has been awarded to India’s Gufic Biosciences Ltd, which will also manufacture the medication.
The contract is valued at USD 702,000, inclusive of cost and freight charges for air transportation.
Both contracts were awarded to the lowest substantially responsive bidders following proposals submitted by the Minister of Health and Mass Media. (Newswire)